New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra)

被引:26
作者
Cotter, J [1 ]
Wooltorton, E [1 ]
机构
[1] Univ Ottawa, Dept Family Med, Ottawa, ON K1N 6N5, Canada
关键词
D O I
10.1503/cmaj.050456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1299 / 1299
页数:1
相关论文
共 3 条
[1]  
*HLTH CAN, 2004, HLTH CAN END IMP SAF
[2]   Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery [J].
Nussmeier, NA ;
Whelton, AA ;
Brown, MT ;
Langford, RM ;
Hoeft, A ;
Parlow, JL ;
Boyce, SW ;
Verburg, KM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1081-1091
[3]   Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention [J].
Solomon, SD ;
McMurray, JJV ;
Pfeffer, MA ;
Wittes, J ;
Fowler, R ;
Finn, P ;
Anderson, WF ;
Zauber, A ;
Hawk, E ;
Bertagnolli, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1071-1080